Panel discussion and conclusion

18 May 2025 (15:36 - 15:45)

Organised by:

Video

Sign in for access options

5 More presentations in this session

Presentation thumbnail

Welcome and introduction

Professor M. Cikes (Zagreb, HR)

Presentation thumbnail

Improving outcomes for the heart and kidney: the role of mineralocorticoid receptor antagonists (MRAs)

Professor B. Bozkurt (Houston, US)

Presentation thumbnail

MRAs in heart failure with reduced rejection fraction (HFrEF): a cornerstone of guideline-recommended medical therapy

Professor M. Cikes (Zagreb, HR)

Presentation thumbnail

Non-steroidal mineralocorticoid receptor antagonists (nsMRAs) in heart failure with mid-range and preserved ejection fraction: establishing a new standard in heart failure care

Professor J. Butler (Dallas, US)

Presentation thumbnail

nsMRAs: what emerging trials tell us about the future of heart failure therapy

Professor J. McMurray (Glasgow, GB)

Access the full session

Session thumbnail

Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation

The Event

Event poster

Heart Failure 2025

18 May 2025 15:36 CET

You may be interested in

Congress Presentation

Deep dive and Q&A: unraveling the differences between MRAs for the treatment of heart and kidney disease. Join a conversation discussing key evidence!

19 May 2025

Congress Presentation

Panel discussion & closing

1 September 2024

Congress Session

Late-Breaking Clinical Trials: advances in heart failure care

31 August 2025

Congress Session

Updates on current heart failure treatment

13 May 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources